BVS
Bioventus Inc
13.30$
+3.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2% | 6.2% | 7.5% | 14.2% | 12.0% | 22.4% | 5.3% | -2.6% | 3.0% | 6.8% | 13.0% | |
| 10.5% | 11.9% | 13.0% | 9.2% | 8.9% | 8.9% | 8.1% | 10.8% | 11.2% | 8.6% | 8.3% | |
| 0.2% | 1.0% | 1.3% | 4.5% | 3.2% | 3.1% | -1.0% | 3.4% | 0.5% | 1.8% | 2.2% | |
| – | – | 11.7% | 9.8% | 6.5% | 5.7% | 2.8% | – | – | – | – | |
| -7.1% | -4.9% | -4.2% | 0.9% | -4.0% | 4.8% | -3.1% | -5.8% | -0.6% | -2.1% | -2.4% | |
| 2.7% | 8.6% | 2.9% | 1.9% | 2.5% | 6.4% | 1.7% | 0.3% | 1.4% | 0.2% | 0.5% | |
| -4.7% | -12.9% | -23.7% | -1.9% | -2.3% | -6.4% | -65.9% | -22.7% | 3.1% | 4.0% | -0.6% | |
| 1.1% | 1.0% | 0.4% | 2.5% | 2.7% | 6.2% | 0.1% | 1.8% | – | – | – | |
| – | – | – | – | – | – | 64.4% | -0.7% | – | – | – | |
| – | – | -0.3% | -1.6% | -0.4% | -3.1% | 38.6% | 11.6% | -4.5% | -10.4% | -7.6% | |
| 2.9% | -2.7% | 12.3% | -4.2% | -3.2% | -9.2% | 63.4% | 12.1% | -5.2% | -9.5% | -10.8% | |
| -0.8% | -10.0% | -4.3% | 8.0% | 6.4% | 6.9% | 2.9% | -13.2% | 1.0% | 0.8% | 1.7% | |
| -1.6% | -2.4% | 4.5% | 12.3% | 9.5% | 15.9% | 3.6% | -2.9% | 1.6% | 6.6% | 12.6% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.